AVBP - ArriVent BioPharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AVBP is currently covered by 6 analysts with an average price target of $35.7. This is a potential upside of $16.58 (86.72%) from yesterday's end of day stock price of $19.12.

ArriVent BioPharma's activity chart (see below) currently has 38 price targets and 45 ratings on display. The stock rating distribution of AVBP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.92% with an average time for these price targets to be met of 110.14 days.

Highest price target for AVBP is $50, Lowest price target is $18, average price target is $35.7.

Most recent stock forecast was given by KALPIT PATEL from B. RILEY. First documented stock forecast 19-Feb-2024.

Currently out of the existing stock ratings of AVBP, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Mar-2025

$29

$10.15 (53.85%)

$45

Buy Since 11-Mar-2026

$29

$10.15 (53.85%)

$29

6 days ago
(15-Oct-2026)

0/4 (0%)

$12.34 (74.07%)

Buy Since 29-Apr-2024

$27

$8.15 (43.24%)

$47

14 days ago
(07-Oct-2026)

4/15 (26.67%)

$10.29 (61.58%)

94

Buy Since 19-Feb-2024

$20

$1.15 (6.10%)

$40

15 days ago
(06-Oct-2026)

4/10 (40%)

$3.11 (18.41%)

198

Buy Since 09-Mar-2025

$18

$-0.85 (-4.51%)

$45

15 days ago
(06-Oct-2026)

1/3 (33.33%)

$1.11 (6.57%)

13

Show more analysts

Please expand the browser size to see the chart

What is AVBP (ArriVent BioPharma) average time for price targets to be met?

On average it took 110 days for the stock forecasts to be reached, with an average price target met ratio of 29.92%.

Which analyst most recently updated their price target on AVBP (ArriVent BioPharma)?

Kalpit Patel

Which analyst has the most public recommendations on AVBP (ArriVent BioPharma)?

Kalpit Patel works at B. RILEY and has 5 price targets and 3 ratings on AVBP

Which analyst is the currently most bullish on AVBP (ArriVent BioPharma)?

Jeff Jones with the highest potential upside of $31.15

Which analyst is the currently most reserved on AVBP (ArriVent BioPharma)?

Corinne Jenkins with the lowest potential downside of -$1
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?